<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>TGF-β signaling provides <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> protection against <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Mechanisms that support its <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressive properties remain unclear </plain></SENT>
<SENT sid="2" pm="."><plain>The ubiquitin ligase Arkadia/RNF111 enhances TGF-β signaling responses by targeting repressors of the pathway for degradation </plain></SENT>
<SENT sid="3" pm="."><plain>The corepressors SnoN/Ski, critical substrates of Arkadia, complex with the activated TGF-β signaling effectors Smad2/3 (pSmad2/3) on the promoters of target genes and block their transcription </plain></SENT>
<SENT sid="4" pm="."><plain>Arkadia degrades this complex including pSmad2/3 and unblocks the promoter </plain></SENT>
<SENT sid="5" pm="."><plain>Here, we report that Arkadia is expressed highly in the mouse colonic epithelium </plain></SENT>
<SENT sid="6" pm="."><plain>Heterozygous Akd(+/-) mice are <z:mpath ids='MPATH_458'>normal</z:mpath> but express less Arkadia </plain></SENT>
<SENT sid="7" pm="."><plain>This leads to reduced expression of several TGF-β target genes, suggesting that <z:mpath ids='MPATH_458'>normal</z:mpath> levels of Arkadia are required for efficient signaling responses </plain></SENT>
<SENT sid="8" pm="."><plain>Critically, Akd(+/-) mice exhibit increased susceptibility to azoxymethane/<z:chebi fb="0" ids="52071">dextran</z:chebi> <z:chebi fb="0" ids="32149">sodium sulfate</z:chebi> carcinogen-induced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, as they develop four-fold more <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> than <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="9" pm="."><plain>Akd(+/-) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> also exhibit a more aggressive pathology, higher proliferation index, and reduced cytostasis </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore, Arkadia functions as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor whose peak expression is required to suppress <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development and progression </plain></SENT>
<SENT sid="11" pm="."><plain>The accumulation of nuclear SnoN and pSmad2, along with the downregulation of TGF-β target genes observed in Akd(+/-) colon and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, suggest that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressing properties of Arkadia are mediated by its ability to derepress TGF-β signaling </plain></SENT>
<SENT sid="12" pm="."><plain>Consistent with this likelihood, we identified mutations in primary <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> from human patients that reduce Arkadia function and are associated with the accumulation of nuclear SNON </plain></SENT>
<SENT sid="13" pm="."><plain>Collectively, our findings reveal that Arkadia enhances TGF-β signaling responses and supports its <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-suppressing properties in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>